The Nephrology Division of the Department of Internal Medicine at the University of Texas Medical Branch in Galveston is dedicated to providing the highest level of patient care, training the next generation of academic nephrology leaders, and to research and innovation that will lead to improved patient outcomes and quality of life.
Our faculty members are committed to providing leading-edge diagnosis and treatment for the entire spectrum of renal disease, with expertise in chronic kidney disease, polycystic kidney disease, renal transplantation, renal pathology, hemodialysis, glomerulonephritis, peritoneal dialysis, electrolyte and acid-base disorders, and kidney stones. We are dedicated to ensuring compassionate, high quality care to patients with end-stage renal disease.
On this site you will find links to physician bios and Curriculum Vitaes; information about our Fellowship Program and other educational endeavors, the location of our outpatient clinics and information about the inpatient units in the John Sealy towers, various ongoing research projects and how to contact us if you have any questions.
The department of internal medicine is developing evidence based clinical protocols which will be available in EPIC (as order sets) for use when admitting patients with these diagnoses. Their AIM is to standardize care and decrease length of stay and readmission rates.Currently available protocols are:
- CAP - Community Acquired Pneumonia Orderset
- Congestive Heart Failure (CHF)
- Chronic Obstructive Pulmonary Disease (COPD)
- Diabetic Ketoacidosis Adult, ICU
- General Medicine Admission
- Immunodeficiency Flow Panel
- MICU/CCU Admission Order Set
- Oral Analgesic Medicaitons
- Parenteral Opioids
- Sepsis, Adult ICU
- 111 - Stroke Alert
- 112 - Stroke Activation
- 300086 - Stroke Floor Admission
- 3000000001 - Stroke Critical care without tPA
- 300088 Stroke - Transfer from Critical care to floor
- 3004002 - Stroke Discharge
All protocols can be found in the EPIC order set section.
The department of Internal Medicine has a large role in the Meaningful Use Initiative. Our participation is key for the success of the initiative. Please visit the meaningful use website for important communication and updates from the Meaningful Use Initiative.